The U.S. Food and Drug Administration is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy ...
The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
Risk of “acute, serious, and life-threatening” heart inflammation is now on the label of Sarepta's gene therapy for Duchenne ...
A menopause researcher breaks down the biggest myths women get wrong about hot flashes, plus the hormonal and non-hormonal ...
Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...
The FDA has cleared home use of a device that helps people with spinal cord injuries regain mobility and functioning.
Trump administration officials, including Health Secretary Robert F. Kennedy Jr., have discussed scaling back the role of ...
Dr. Marty Makary is scrambling to hang onto his powers as the Food and Drug Administration commissioner as Health and Human ...
UnitedHealth Group said on Tuesday it had named former U.S. Food and Drug Administration commissioner Scott Gottlieb to its ...
Health Secretary Robert F. Kennedy Jr. considered installing a new leader to manage the agency on a day-to-day basis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback